Technical Analysis for GLUE - Monte Rosa Therapeutics, Inc.

Grade Last Price % Change Price Change
F 17.49 5.81% 0.96
GLUE closed up 5.81 percent on Tuesday, December 7, 2021, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical GLUE trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New Downtrend Bearish 5.81%
Narrow Range Bar Range Contraction 5.81%
NR7 Range Contraction 5.81%
Inside Day Range Contraction 5.81%
Wide Bands Range Expansion 5.81%
Oversold Stochastic Weakness 5.81%
New 52 Week Closing Low Bearish 7.43%
Older End-of-Day Signals for GLUE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 10% about 23 hours ago
60 Minute Opening Range Breakout about 23 hours ago
10 DMA Resistance about 23 hours ago
Rose Above Previous Day's High about 24 hours ago
Up 5% about 24 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Monte Rosa Therapeutics, Inc. Description

Monte Rosa Therapeutics is a biotechnology company developing a portfolio of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins. The company has developed a proprietary protein degradation platform, called QuEEN™, that enables it to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates that are designed to eliminate therapeutically relevant proteins in a highly selective manner. The company’s drug discovery platform combines diverse and proprietary chemical libraries of small molecule protein degraders with in-house proteomics, structural biology, machine learning-based target selection and computational chemistry capabilities to predict and obtain protein degradation profiles. Monte Rosa was launched from founding investor Versant Ventures’ Ridgeline Discovery Engine and is headquartered in Boston, Mass., with research operations in both Boston and Basel, Switzerland.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Drug Discovery Machine Learning Proteomics

Is GLUE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 45.56
52 Week Low 15.67
Average Volume 123,903
200-Day Moving Average 0.00
50-Day Moving Average 21.73
20-Day Moving Average 20.12
10-Day Moving Average 18.06
Average True Range 2.03
ADX 25.27
+DI 16.90
-DI 26.56
Chandelier Exit (Long, 3 ATRs) 20.65
Chandelier Exit (Short, 3 ATRs) 21.75
Upper Bollinger Bands 25.26
Lower Bollinger Band 14.98
Percent B (%b) 0.24
BandWidth 51.11
MACD Line -1.82
MACD Signal Line -1.54
MACD Histogram -0.2764
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.64
Resistance 3 (R3) 19.66 18.96 19.28
Resistance 2 (R2) 18.96 18.42 18.95 19.16
Resistance 1 (R1) 18.23 18.08 18.60 18.21 19.04
Pivot Point 17.53 17.53 17.71 17.52 17.53
Support 1 (S1) 16.79 16.98 17.16 16.77 15.94
Support 2 (S2) 16.09 16.64 16.08 15.82
Support 3 (S3) 15.36 16.09 15.70
Support 4 (S4) 15.34